Hyfe.ai: Revolutionizing Respiratory Health Monitoring with AI-Powered Cough Detection

Hyfe.ai is a pioneering AI-driven health technology platform that enables continuous, passive, and privacy-preserving cough monitoring for respiratory conditions such as COPD, asthma, CHF, IPF, lung cancer, and COVID-19. Designed for seamless integration across wearables, smartphones, and smartwatches, Hyfe.ai’s on-device AI algorithms analyze cough patterns in real time without recording or transmitting audio, ensuring patient confidentiality. Trusted by thousands of patients and leading institutions worldwide, including Johns Hopkins University and Imperial College London, the platform supports clinical research, remote patient monitoring, and digital therapeutics development. With a proven track record in 46 global clinical trials and over 27.1 billion cough data points processed, Hyfe.ai delivers high accuracy—90% sensitivity and just 1 false positive per hour—making it a reliable tool for healthcare providers, pharmaceutical companies, and academic researchers.

Key Features:

• Continuous Cough Monitoring: Enables long-term tracking of cough frequency and patterns for weeks, months, or even years.
• On-Device AI Processing: All audio analysis occurs locally on the user’s device; no audio is sent to servers, preserving full patient privacy.
• Passive Data Collection: Cough detection happens automatically without requiring user interaction.
• Multi-Device Compatibility: Works across smartphones, smartwatches, and wearables with built-in microphones.
• Clinical-Grade Accuracy: Validated in real-world trials with 90% sensitivity and 1 false positive per hour.
• Digital Therapeutics Integration: Developing prescription digital therapeutics for chronic cough and respiratory disease management.
• Support for Multiple Respiratory Conditions: Designed for asthma, COPD, CHF, IPF, lung cancer, and post-COVID recovery monitoring.
• Scalable Remote Monitoring: Facilitates large-scale, remote patient data collection for clinical research and real-world evidence.
• Comprehensive Dashboard & Analytics: Offers a detailed, real-time view of cough trends and patient health insights for clinicians and researchers.
• Research-Backed Technology: Supported by published studies in high-impact journals like The Lancet and the Korean Journal of Medicine.
• Partnerships with Leading Institutions: Collaborates with CRCHUM, Fudan University, University of Pittsburgh, and Imperial College London.
• Integration with LEAP Platform: Partnered with ActiGraph to deliver advanced cough monitoring in clinical research settings.

Pricing: Hyfe.ai offers a freemium model with access to core monitoring features for free, while advanced analytics, research tools, and digital therapeutic integrations are available through paid subscription tiers tailored to pharma, academic, and healthcare provider needs.

Conclusion: Hyfe.ai is a transformative, privacy-first AI solution for respiratory health, delivering clinically validated, real-time cough monitoring that empowers researchers, healthcare providers, and patients with actionable insights—making it a vital tool in modern digital therapeutics and remote patient care.